Greenlee, R. T., Hill-Harmon, M. B., Murray, T., et al. Cancer statistics. CA Cancer J Clin (2001), 51:15–36.CrossRefGoogle ScholarPubMed

Calle, E. E., Rodriguez, C., Walker-Thurmond, K., et al. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med (2003), 348:1625–38.CrossRefGoogle Scholar

Marsden, D. E., Friedlander, M. and Hacker, N. F.. Current management of epithelial ovarian carcinoma: a review. Semin Surg Oncol (2000), 19:11–19.3.0.CO;2-3>CrossRefGoogle ScholarPubMed

Jacobs, I. J., Skates, S. J., MacDonald, N., et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet (1999), 353:1207–10.CrossRefGoogle ScholarPubMed

Pothuri, B., Leitao, M., Baracat, R., et al. Genetic analysis of ovarian carcinoma histogenesis. Gynecol Oncol (2001), 80:277.Google Scholar

Wen, W. H., Reles, A., Runnebaum, I. B., et al. p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol (1999), 18:29–41.CrossRefGoogle ScholarPubMed

Schildkraut, J. M., Bastos, E. and Berchuck, A.. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst (1997), 89:932–8.CrossRefGoogle ScholarPubMed

McClamrock, D. and Adashi, E. Y.. Polycystic ovarian syndrome and associated hirsutism in the adolescent. Adol Ped Gynecol (1992), 5:231–41.CrossRefGoogle Scholar

Ovarian Tumour Panel of the Royal College of Obstetricians and Gynaecologists. Ovarian epithelial tumours of borderline malignancy: pathological features and current status. Br J Obstet Gynaecol (1983), 90:743–50.

Fox, H.. Ovarian tumours of borderline malignancy: time for a reappraisal?Curr Diagnost Pathol (1996), 3:143–51.CrossRefGoogle Scholar

Bell, D. A. and Scully, R. E.. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol (1990), 21:397–403.CrossRefGoogle ScholarPubMed

Karseladze, A. I.. On the site of origin of epithelial tumors of the ovary. J Gynaecol Oncol (2001), 22:110–15.Google ScholarPubMed

Rutgers, J. L. and Scully, R. E.. Ovarian mullerian mucinous papillary cystadenocarcinomas of borderline malignancy. A clinicopathologic analysis. Cancer (1988), 61:340–8.3.0.CO;2-U>CrossRefGoogle Scholar

Cannistra, S. A.. Cancer of the ovary. N Engl J Med (1993), 329:1550–8.CrossRefGoogle ScholarPubMed

Schildkraut, J. M. and Thompson, W. D.. Familial ovarian cancer: a population based case-control study. Am J Epidemiol (1988), 128:456–66.CrossRefGoogle ScholarPubMed

R. P. Zweemer. Overview of the aetiology of familial ovarian cancer. In Jacobs, I. J., Shepherd, J. H., Oram, D. H., Blackett, A. D., Luesley, D. M., Berchuck, A., Hudson, C. N., eds., Ovarian Cancer (Oxford: Oxford University Press, 2002), pp. 29–35.Google Scholar

Boyd, M., Harris, F., McFarlane, R., et al. A human, BRCA1 gene knockout. Nature (1995), 375:541–2.CrossRefGoogle ScholarPubMed

Kinzler, K. W. and Vogelstein, B.. Gatekeepers and caretakers. Nature (1997), 386:761–3.CrossRefGoogle ScholarPubMed

Berchuck, A., Kohler, M. F., Marks, J. R., et al. The p53 tumor suppressor gene frequently is altered in gynecological cancers. Am J Obstet Gynecol (1994), 170:246–52.CrossRefGoogle Scholar

Ginolhac, S. M., Gad, S., Corbex, M., et al. BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations. Cancer Epidemiol Biomarkers Prev (2003), 12:90–5.Google ScholarPubMed

Gilks, C. B., Bell, D. A. and Scully, R. E.. Serous psammocarcinoma of the ovary and peritoneum. Int J Gynecol Pathol (1990), 9:110–21.CrossRefGoogle ScholarPubMed

Lee, K. R. and Scully, R. E.. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with pseudomyxoma peritonei. Am J Surg Pathol (2000), 24:1447–64.CrossRefGoogle Scholar

Hoerl, H. D. and Hart, W. R.. Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow up. Am J Surg Pathol (1998), 22:1449–62.CrossRefGoogle ScholarPubMed

Siraaunkgul, S., Robbins, K. M., McGowan, L., et al. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and mullerian type. Int J Gynecol Pathol (1995), 14:198–208.CrossRefGoogle Scholar

Ronnet, B. M., Kurman, R. J., Schmookler, B. M., et al. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol (1997), 21:1144–56.CrossRefGoogle Scholar

Katsube, Y., Berg, J. W. and Silverberg, S. G.. Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area 1 July–31 December 1969 and 1 July–31 December 1979. Int J Gynecol Pathol (1982), 1:3–16.CrossRefGoogle ScholarPubMed

R. E. Scully, D. A. Bell and G. M. Abu-Jawdeh, Update on early ovarian cancer developing in benign ovarian tumors. In Mason, P., Sharp, P., Blackett, T., Berek, J., eds., Ovarian Cancer 3 (London: Chapman, Hall, 1995), pp. 139–44.Google Scholar

Brincat, M., Galea, R. and Buhagiar, A.. Polycystic ovaries and endometriosis: a possible connection. Br J Obstet Gynaecol (1994), 101:346–8.CrossRefGoogle ScholarPubMed

Mahmood, T. A. and Templeton, A.. Prevalence and genesis of endometriosis. Hum Reprod (1991), 6:544–9.CrossRefGoogle ScholarPubMed

Kline, R. C., Wharton, J. T., Atkinson, E. N., et al. Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol (1980), 39:337–46.CrossRefGoogle Scholar

Falkenberry, S. S., Stainhoff, M. M., Gordinier, M., et al. Synchronous endometrioid tumors of the ovary and endometrium. A clinicopathologic study of 22 cases. J Reprod Med (1996), 41:713–18.Google ScholarPubMed

Smit, V. T., Cornelisse, C. J., Jong, D., et al. Analysis of tumor heterogeneity in a patient with synchronously occurring female genital tract malignancies by DNA flow cytometry, DNA fingerprinting and immunohistochemistry. Cancer (1988), 62:1146–52.3.0.CO;2-D>CrossRefGoogle Scholar

Lele, S. B., Piver, M. S., Barlow, J. J., et al. Squamous cell carcinoma arising in ovarian endometriosis. Gynecol Oncol (1978), 6:290–3.CrossRefGoogle ScholarPubMed

Young, R. H., Prat, J. and Scully, R. E.. Ovarian endometrioid carcinomas resembling sex cord stromal tumours. A clinicopathological analysis of 13 cases. Am J Surg Pathol (1982), 6:513–22.CrossRefGoogle ScholarPubMed

Scully, R. E., Young, R. H. and Clement, P. B., eds. Atlas of Tumor Pathology: Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tubes, and Broad Ligament, 3rd edn., (Washington, DC: Armed Forces Institute of Pathology, 1998).Google Scholar

Tomos, C., Silva, E. G., Khorana, S. M., et al. High stage endometrioid carcinoma of the ovary. Prognostic significance of pure versus mixed histologic types. Am J Surg Path (1994), 18:687–93.Google Scholar

Pokieser, W., Schmerker, R., Kisser, M., et al. Clear cell carcinoma arising in endometriosis of the rectum following progestin therapy. Path Res Pract (2002), 198:121–4.CrossRefGoogle ScholarPubMed

Cirisano, F. D. Jr, Robboy, S. J., Dodge, R. K., et al. The outcome of stage I–II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol (2000), 77:55–65.CrossRefGoogle ScholarPubMed

Ordonez, N. G.. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different. Histopathology (2000), 36:433–8.CrossRefGoogle ScholarPubMed

Reidel, I., Czernobilsky, B., Lifschitz-Mercer, B., et al. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchows Arch (2001), 438:181–91.CrossRefGoogle Scholar

Costa, M. J., Hansen, C., Dickerman, A., et al. Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalised ovarian epithelial tumors (stages 2–4). Am J Clin Pathol (1998), 109:173–80.CrossRefGoogle Scholar

Vortmejey, A. O., Devouassoux-Shisheboran, M., Li, G., et al. Microdissection based analysis of mature ovarian teratoma. Am J Pathol (1999), 154:987–91.CrossRefGoogle Scholar

Kleiman, G. M., Young, R. H. and Scully, R. E.. Primary neuroectodermal tumors of the ovary. A report of 25 cases. Am J Surg Pathol (1993), 17:764–78.CrossRefGoogle Scholar

Zaloudek, C. J., Tavassoli, F. A. and Norris, H. J.. Dysgerminoma with syncytiotrophoblastic giant cells. A histologically and clinically distinctive subtype of dysgerminoma. Am J Surg Pathol (1981), 5:361–7.CrossRefGoogle ScholarPubMed

Lifschitz-Mercer, B., Walt, H., Kushnir, I., et al. Differentiation potential of ovarian dysgerminoma: an immunohistochemical study of 15 cases. Hum Pathol (1995), 26:62–6.CrossRefGoogle ScholarPubMed

Niehans, G. A., Manivel, J. C., Copland, G. T., et al. Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer (1988), 62:1113–23.3.0.CO;2-0>CrossRefGoogle ScholarPubMed

Nogales, F. F.. Embryonic clues to human yolk sac tumors: a review. Int J Gynecol Pathol (1993), 12:101–7.CrossRefGoogle ScholarPubMed

King, B. F. and Enders, A. C., The Human Yolk Sac and Yolk Sac Tumours. Berlin: Springer, 1993.Google Scholar

Gee, D. C. and Russell, P.. The pathological assessment of ovarian neoplasms. IV. The sex cord stromal tumours. Pathology (1981), 13:235–55.CrossRefGoogle ScholarPubMed

N. Singh, and D. G. Lowe. Primary non-epithelial ovarian cancers. In Jacobs, I. J., Shepherd, J. H., Oram, D. H., Blackett, A. D., Luesley, D. M., Berchuck, A., Hudson, C. N., eds., Ovarian Cancer (Oxford: Oxford University Press 2002), pp. 75–84.Google Scholar

Clement, P. B., Young, R. H., Hanna, W., et al. Sclerosing peritonitis associated with luteinised thecomas of the ovary. A clinicopathologic study of six cases. Am J Surg Pathol (1994), 18:1–13.CrossRefGoogle Scholar

Meigs, J. V.. Fibroma of the ovary with ascites and hydrothorax. Meigs' syndrome. Am J Obstet Gynecol (1954), 67:962–87.CrossRefGoogle ScholarPubMed

Dumont-Herslowitz, R. A., Safaii, H. S. and Senior, B.. Ovarian fibromata in four successive generations. J Pedriatr (1978), 93:621–4.CrossRefGoogle Scholar

Prat, J. and Scully, R. E.. Cellular fibromas and fibrosarcomas of the ovary: a comparative clinicopathologic analysis of seventeen cases. Cancer (1981), 47:2663–70.3.0.CO;2-V>CrossRefGoogle ScholarPubMed

Prat, J., Young, R. H. and Scully, R. E.. Ovarian Sertoli-Leydig cell tumors with heterologous elements. II Cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases. Cancer (1982), 50:2465–75.3.0.CO;2-U>CrossRefGoogle ScholarPubMed

Zheng, W., Sung, C. J., Hanna, I., et al. α and β subunits of inhibin/activin as sex cord stromal differentiation markers. Int J Gynecol Pathol (1997), 16:263–71.CrossRefGoogle ScholarPubMed

Kruckenberg, P.. Ueben das Fibrosarcoma ovarii mucocellulari (carcinomatase). Archiv Gynecol (1896), 50:287–321.Google Scholar

Singh, N., and Lowe, D. G.. Metastases in the ovary. In Jacobs, I. J., Shepherd, J. H., Oram, D. H., Blackett, A. D., Luesley, D. M., Berchuck, A., Hudson, C. N., eds., Ovarian Cancer (Oxford: Oxford University Press 2002), 785–9.Google Scholar

Lathrop, J. C.. Malignant pelvic lymphomas. Obstet Gynaecol (1967), 30:137–45.Google ScholarPubMed

Scully, R. E.. World Health Organization classification and nomenclature of ovarian cancer. Natl Cancer Inst Monogr (1975), 42:5–7.